Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Randomized, Double-Blind, Placebo-Controlled Trial of Meriva® (Curcumin) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis
Brief Summary: This randomized phase IIb trial studies how well curcumin works in preventing gastric cancer in patients with chronic atrophic gastritis and/or gastric intestinal metaplasia. Curcumin is an antioxidant compound found in plants that may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.